- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07761260
BSPTS and Core Stabilization Exercises in Adolescents With Idiopathic Scoliosis
August 8, 2026 updated by: Yunus Emre Tutuneken, Istinye University
Effects of Core Stabilization Exercises Combined With Barcelona Scoliosis Physical Therapy School Exercises on Trunk Rotation Angle and Core Muscle Endurance in Individuals With Adolescent Idiopathic Scoliosis: A Randomized Controlled Study
This study aims to investigate the short-term effects of adding core stabilization exercises to Barcelona Scoliosis Physical Therapy School (BSPTS) exercises in adolescents with idiopathic scoliosis.
Participants will be randomly assigned to either a BSPTS exercise group or a BSPTS plus core stabilization exercise group.
Both groups will participate in supervised exercise sessions twice a week for 6 weeks.
The study will evaluate changes in trunk rotation angle and core muscle endurance as the primary outcomes, as well as dynamic balance, spinal appearance perception, postural awareness, and scoliosis-related quality of life.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
36
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosis of adolescent idiopathic scoliosis.
- Cobb angle between 10° and 40°.
- Risser sign between 0 and 3.
- Ability to understand and perform the exercise instructions.
- Willingness to participate in the study and provision of informed consent.
Exclusion Criteria:
- Scoliosis associated with congenital, neuromuscular, or syndromic conditions.
- Previous spinal surgery.
- Presence of significant lower-extremity deformity or neurological disorder affecting balance or exercise performance.
- Current participation in another scoliosis-specific exercise program.
- Severe cardiopulmonary or systemic disease contraindicating exercise.
- Inability to complete the assessment procedures or exercise program.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: BSPTS Plus Core Stabilization Exercise Group
|
Participants will receive the same BSPTS-based scoliosis-specific exercise program, combined with core stabilization exercises targeting activation of the transversus abdominis, multifidus, and other deep trunk muscles.
Sessions will be conducted under the supervision of a physiotherapist for 45 minutes, twice weekly for 6 weeks.
|
|
Active Comparator: BSPTS Exercise Group
|
Participants will receive a Barcelona Scoliosis Physical Therapy School (BSPTS)-based scoliosis-specific exercise program.
The program will include three-dimensional self-correction exercises focusing on spinal elongation, derotation, and sagittal plane alignment.
Sessions will be conducted under the supervision of a physiotherapist for 45 minutes, twice weekly for 6 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trunk Rotation Angle
Time Frame: Baseline and immediately after the 6-week intervention.
|
Trunk rotation angle measured using a scoliometer during the Adams Forward Bend Test.
|
Baseline and immediately after the 6-week intervention.
|
|
Core Muscle Endurance
Time Frame: Baseline and immediately after the 6-week intervention.
|
Core muscle endurance assessed using the McGill Core Endurance Test Battery, including trunk flexor, trunk extensor, and right and left lateral plank tests.
|
Baseline and immediately after the 6-week intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dynamic Balance
Time Frame: Baseline and immediately after the 6-week intervention.
|
Dynamic balance assessed using the Y-Balance Test.
|
Baseline and immediately after the 6-week intervention.
|
|
Spinal Appearance Perception
Time Frame: Baseline and immediately after the 6-week intervention.
|
Spinal appearance perception assessed using the Spinal Appearance Questionnaire (SAQ).
|
Baseline and immediately after the 6-week intervention.
|
|
Postural Awareness
Time Frame: Baseline and immediately after the 6-week intervention.
|
Postural awareness assessed using the Postural Awareness Scale (PAS).
|
Baseline and immediately after the 6-week intervention.
|
|
Scoliosis-Related Quality of Life
Time Frame: Baseline and immediately after the 6-week intervention.
|
Quality of life, functional status, and psychosocial impact assessed using the Scoliosis Research Society-22 (SRS-22) questionnaire.
|
Baseline and immediately after the 6-week intervention.
|
|
Global Perceived Change
Time Frame: Immediately after the 6-week intervention.
|
Perceived change following treatment assessed using the Global Rating of Change Scale.
|
Immediately after the 6-week intervention.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 20, 2026
Primary Completion (Estimated)
March 25, 2027
Study Completion (Estimated)
March 25, 2027
Study Registration Dates
First Submitted
August 8, 2026
First Submitted That Met QC Criteria
August 8, 2026
First Posted (Actual)
August 12, 2026
Study Record Updates
Last Update Posted (Actual)
August 12, 2026
Last Update Submitted That Met QC Criteria
August 8, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 103
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.